Physician profile
Sara J Dezell
NPI 1801244199
$227,656.32
in general payments reported to CMS, 2019-2025
9 companies · $83K in 2025
The $83K reported for 2025 was more than what 99% of Clinical Nurse Specialist providers received nationally (typical 2025 total: $150).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $5,401 · 2022: $36K · 2023: $44K · 2024: $59K · 2025: $83K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $108K · Travel and Lodging: $35K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $31K · Food and Beverage: $13K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $107,668.75 |
| Travel and Lodging | $35,024.71 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $30,765.50 |
| Food and Beverage | $12,971.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $191,646.68 | 2021-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia |
| Boston Scientific Corporation | $16,828.49 | 2021-2025 | Sentinel, Rotapro |
| Medtronic, INC. | $9,525.10 | 2021-2025 | Corevalve Evolut R |
| Abbott Laboratories | $9,447.31 | 2021-2025 | Mitraclip, Triclip, Portico |
| Cardiac Dimensions, INC. | $115.87 | 2023 | |
| Abiomed | $42.54 | 2025 | |
| Actelion Pharmaceuticals US, INC. | $20.83 | 2025 | Uptravi, Opsumit |
| Cvrx, INC. | $15.21 | 2025 | Barostim Neo System |
| Angiodynamics, INC. | $14.29 | 2025 | Alphavac |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sara Dezell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.